Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

LeEject 2 Dental Syringe and Needle System

N.º K: K171254 · 2017-11-16

SolicitanteAdvanced Technology and Capital, Inc.
Fecha de decisión2017-11-16
Código de productoEJI
Comité asesorDE
DecisiónSubstantially Equivalent

Resumen del dispositivo

LeEject 2 Dental Syringe and Needle System is the device name listed in this FDA 510(k) record. The listed applicant is Advanced Technology and Capital, Inc.. It received FDA 510(k) clearance on 2017-11-16 under 510(k) number K171254. The device is classified under product code EJI. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the LeEject 2 Dental Syringe and Needle System?

LeEject 2 Dental Syringe and Needle System is a medical device that received FDA 510(k) clearance on 2017-11-16. The listed applicant is Advanced Technology and Capital, Inc.. The 510(k) number is K171254.

When did LeEject 2 Dental Syringe and Needle System receive FDA 510(k) clearance?

LeEject 2 Dental Syringe and Needle System received FDA 510(k) clearance on 2017-11-16, under 510(k) number K171254.

Who is the listed applicant for LeEject 2 Dental Syringe and Needle System?

The FDA 510(k) record lists Advanced Technology and Capital, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LeEject 2 Dental Syringe and Needle System?

The FDA product code for LeEject 2 Dental Syringe and Needle System is EJI.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑